The non-responding pneumonia

R. Menendez (Valencia, Spain)

Source: Annual Congress 2005 - Difficult infections in the respiratory patient
Session: Difficult infections in the respiratory patient
Session type: Symposium
Number: 210
Disease area: Respiratory infections

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Menendez (Valencia, Spain). The non-responding pneumonia. Annual Congress 2005 - Difficult infections in the respiratory patient

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia
Source: Eur Respir J 2011; 38: 1158-1164
Year: 2011



BAL in pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 5s
Year: 2006

BAL in pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 1s
Year: 2006

Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia
Source: Eur Respir J 2013; 41: 1378-1385
Year: 2013



The comparison of bronchoalveolar lavage (BAL) with mini-BAL in pneumonia developed in immunocompromised patients
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009


Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
Source: Eur Respir J 2009; 34: 1364-1375
Year: 2009



Eosinophilic pneumonia (acute, chronic)
Source: Respipedia Article
Year: 2017

Cryptogenic organising pneumonia - COP
Source: Respipedia Article
Year: 2016

Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia
Source: Eur Respir J 2008; 32: 726-732
Year: 2008



Microbial investigation in ventilator-associated pneumonia
Source: Eur Respir J 2001; 17: 791-801
Year: 2001



Procalcitonin and C reactive protein as markers of treatment failure in community-acquired pneumonia
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012



The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 347s
Year: 2006

Systemic inflammatory response after bronchoalveolar lavage in critically ill patients
Source: Eur Respir J 2001; 17: 274-280
Year: 2001



The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP)
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013


Could procalcitonin (PCT) be a marker of effectiveness of antibiotic treatment (ABT) in pregnant with not severe community-acquired pneumonia (CAP)?
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Diagnostic accuracy of inflammatory biomarkers in bronchoalveolar lavage from patients with ventilator-associated pneumonia
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients
Source: Eur Respir J 2002; 20: 982-989
Year: 2002



Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007